Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review.

The Journal of the American Academy of Orthopaedic Surgeons
Douglas R HaaseKyle R Sweeney

Abstract

Endoprosthetic reconstruction presents a significant risk of perioperative blood loss. Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss in orthopaedic procedures. The safety and efficacy of TXA in arthroplasty are well documented. There is, however, a dearth of literature exploring the safety and efficacy of TXA in musculoskeletal oncology patients. This retrospective, comparative study explores the effects of TXA on perioperative blood loss, blood transfusion rates, venous thromboembolism (VTE) occurrence, and hospital stay in patients undergoing resection of an aggressive bone tumor and endoprosthetic reconstruction. For the study, charts from a total of 90 patients who underwent resection of an aggressive bone tumor and endoprosthetic reconstruction were reviewed; of these patients, 34 were in the TXA group and 56 in the non-TXA group. Study participants composed of a heterogeneous group of patients with primary bone sarcoma and metastatic osseous disease. Patients in the TXA group received 1 g of topical TXA administered into the wound bed before closure. The Hemoglobin Balance method was used to calculate blood loss. Patients were followed for 6 weeks. Patients undergoing proximal femur replacem...Continue Reading

References

Jan 1, 1996·Current Medical Research and Opinion·F Mercuriali, G Inghilleri
Nov 14, 1997·Transfusion·M E BrecherL T Goodnough
Feb 16, 2000·British Journal of Anaesthesia·A J JansenK Jochmans
Sep 30, 2000·Archives of Orthopaedic and Trauma Surgery·K IdoS Kuriyama
May 26, 2001·International Orthopaedics·O CharroisJ P Courpied
Aug 14, 2001·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·N RosencherI Abraham
Aug 1, 2006·The Journal of Bone and Joint Surgery. British Volume·N B Foss, H Kehlet
Nov 5, 2010·The Journal of Bone and Joint Surgery. American Volume·Jean WongFrances Chung
Apr 23, 2011·Clinical Orthopaedics and Related Research·Keerati Charoencholvanich, Pichet Siriwattanasakul
Jun 19, 2012·The Journal of Arthroplasty·Norio ImaiNaoto Endo
May 2, 2013·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Federica Vigna-TagliantiRoberto Russo
Jun 25, 2013·The Journal of Arthroplasty·Tyler C WindJoseph T Moskal
Jul 3, 2013·Clinical Orthopaedics and Related Research·Daniel R WhitingRafael J Sierra
Aug 3, 2013·The Journal of Arthroplasty·Andrew G GeorgiadisMichael W Laker
Sep 27, 2013·The Journal of Arthroplasty·George F ChimentoSheena Babin
Jan 5, 2014·Clinical Orthopaedics and Related Research·Chih-Hsiang ChangMel S Lee
Mar 19, 2014·The Journal of Arthroplasty·John R TuttleLee E Rubin
Jul 13, 2014·The Journal of Arthroplasty·Christopher SamujhArthur L Malkani
Sep 3, 2014·Archives of Orthopaedic and Trauma Surgery·Luigi SabatiniAlessandro Massè
Nov 3, 2015·Chinese Medical Journal·Fu-Qiang GaoHong Zhang
Apr 29, 2016·Journal of Orthopaedic Surgery·N GoyalS J MacDessi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.